Sanderson, K. (2021). COVID vaccines protect against Delta, but their effectiveness wanes. Nature. https://doi.org/10.1038/d41586-021-02261-8

Jess Rohmann. (2021, March 16). New @PEI_Germany report provides much needed clarity to the #AstraZeneca “pause” in Germany. Not yet available in English. I will try to summarize. /Thread https://t.co/Ev9p2TOdfD [Tweet]. @JLRohmann. https://twitter.com/JLRohmann/status/1371833745272156163

Jess Rohmann. (2021, March 16). New @PEI_Germany report provides much needed clarity to the #AstraZeneca ‘pause’ in Germany. Not yet available in English. I will try to summarize. /Thread https://t.co/Ev9p2TOdfD [Tweet]. @JLRohmann. https://twitter.com/JLRohmann/status/1371833745272156163

Hilda Bastian, PhD. (2021, February 6). Unofficial unnamed AstraZeneca insider says they are doing the interim analysis for the US trial of the Oxford vaccine. AstraZeneca spokesperson says 4-6 weeks till data release. Https://t.co/VUHgbHN02d One is wrong? Or they’ll release only when have FDA minimum follow-up? Https://t.co/LgjfX8AIti [Tweet]. @hildabast. https://twitter.com/hildabast/status/1357862227106095105

John Lichfield. (2021, April 10). Weekly French vaccination thread. The French roll-out, still described as “stuttering” or “glacial” in UK media (and even some Fr media) continues to boom. Over 500,000 doses (1st/ 2nd) were given yesterday, a record. Fr should exceed its 10m 1st jabs 15 April target by 2m. 1/12 https://t.co/hhJa8rafCV [Tweet]. @john_lichfield. https://twitter.com/john_lichfield/status/1380807805960130561

Michael McCarthy. (2021, August 27). #COVD19 vax rates are still increasing in Australia. The over 70s are approaching 90% with first doses. The red line is the rate for all people >=16. That should reach 60% soon. Https://t.co/NH3Q7jumgT [Tweet]. @mickresearch. https://twitter.com/mickresearch/status/1431185640884826112

ReconfigBehSci on Twitter: ‘RT @d_spiegel: Reports of 6 cases of cerebral venous sinus thromboses (CVST) in younger women Germany following 1.6 million AZ vaccines htt…’ / Twitter. (n.d.). Retrieved 17 March 2021, from https://twitter.com/SciBeh/status/1372137512907444228

Michael Bang Petersen. (2021, March 17). This is worsened as costs of #covid19 are not mentally similar to costs of side effects, even if the latter are less risky. People prefer controllable risks to uncontrollabe risks, even if less lethal (https://t.co/kSIcObWYmT). That is why you fear flying but not driving. [2/2] [Tweet]. @M_B_Petersen. https://twitter.com/M_B_Petersen/status/1372103708218159109

ReconfigBehSci. (2020, October 31). RT @learnfromerror: PHIL STAT FORUM NOVEMBER 19; STEPHEN SENN ‘Randomisation and Control in the Age of Coronavirus?’ https://t.co/hqT8GWTqC… [Tweet]. @SciBeh. https://twitter.com/SciBeh/status/1323311706609721344

Kai Kupferschmidt. (2021, March 16). “I’m not here to give you the outcome of any scientific review”, says EMA director Emer Cooke at start of press conference on AstraZeneca vaccine safety. ‘I’m here to explain the steps in the process, what we’re doing, and when you can expect us to come to a conclusion.’ [Tweet]. @kakape. https://twitter.com/kakape/status/1371811123197001729

ReconfigBehSci. (2021, March 18). EMA rules AZ ‘safe and effective’ and benefits outweigh risks... [Tweet]. @SciBeh. https://twitter.com/SciBeh/status/1372584269529419776

Prof. Christina Pagel. (2021, May 23). LONG THREAD on B.1.617.2 & latest PHE data covering: 1) latest tech report on B.1.617.2 (aka ‘India’ variant) 2) vaccine efficacy against B.1.617.2 3) consequences for roadmap 4) avoidability... Or not. [Tweet]. @chrischirp. https://twitter.com/chrischirp/status/1396574267349872644

Myths about COVID-19 vaccination. (n.d.). HackMD. Retrieved March 23, 2022, from https://hackmd.io/@scibehC19vax/misinfo_myths

Pottegård, A., & Klungel, O. H. (2022). The neurological safety of covid-19 vaccines. BMJ, 376, o522. https://doi.org/10.1136/bmj.o522

Mar 03, M. V. B. | N. W. | C. N. | & 2022. (n.d.). Third vaccine dose boosts Omicron protection, with some waning. CIDRAP. Retrieved 7 March 2022, from https://www.cidrap.umn.edu/news-perspective/2022/03/third-vaccine-dose-boosts-omicron-protection-some-waning

Jonathan Li on Twitter: “There’s a lineage of Omicron that’s gained the R346K mutation (BA.1.1). This one could spell some trouble for the AZ mAb (tixagevimab/cilgavimab, Evusheld) that’s being used for pre-exposure prophylaxis. If you want to learn about tix/cil vs Omicron, read on 1/7” / Twitter. (n.d.). Retrieved February 6, 2022, from https://twitter.com/DrJLi/status/1487479972293853188

Nature Portfolio. (2021, October 15). A study in @NatureMedicine indicates that the effectiveness of the Pfizer/BioNTech and Oxford-AstraZeneca vaccines against SARS-CoV-2 infections with symptoms or high viral burden is reduced with the Delta variant compared to the Alpha variant. Https://go.nature.com/3vecpoj https://t.co/XQdnMYguFz [Tweet]. @NaturePortfolio. https://twitter.com/NaturePortfolio/status/1449145321188216836

Khairy Jamaluddin 🇲🇾🌺. (2021, November 14). Real world data from Chile has shown significant increase in vaccine effectiveness after a booster for people who took Sinovac for their primary series. Biggest boost came with a Pfizer booster. Other countries are also combining SSP. Take the booster when offered. Https://t.co/N98K1eEvTR [Tweet]. @Khairykj. https://twitter.com/Khairykj/status/1459800517635305474

Eric Topol. (2021, October 27). 'The benefit of a third [booster] dose in reducing transmission is sizeable and increases with vaccine coverage and contact rates among individuals." https://medrxiv.org/content/10.1101/2021.10.25.21265500v1 by @billygardner and @DiseaseEcology https://t.co/zAZcJgF1nJ [Tweet]. @EricTopol. https://twitter.com/EricTopol/status/1453153076165021696

ReconfigBehSci. (2021, December 13). RT @DrEricDing: 11) Omicron is doubling every 1.6 days in UK 🇬🇧 according to @DrWilliamKu’s figure. That’s way faster growth than in South… [Tweet]. @SciBeh. https://twitter.com/SciBeh/status/1470451594378502154

Munro, A. P. S., Janani, L., Cornelius, V., Aley, P. K., Babbage, G., Baxter, D., Bula, M., Cathie, K., Chatterjee, K., Dodd, K., Enever, Y., Gokani, K., Goodman, A. L., Green, C. A., Harndahl, L., Haughney, J., Hicks, A., van der Klaauw, A. A., Kwok, J., … Appleby, K. (2021). Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): A blinded, multicentre, randomised, controlled, phase 2 trial. The Lancet, S0140673621027173. https://doi.org/10.1016/S0140-6736(21)02717-3 s

Campbell, L., Belam, M., & Lock, S. (2021, December 2). Covid live: Germany set to impose restrictions on the unvaccinated; India detects two cases of Omicron variant. The Guardian. https://www.theguardian.com/world/live/2021/dec/02/coronavirus-news-live-south-africa-sees-exponential-increase-in-covid-cases-dominated-by-omicron-variant

Lovett, S. (2021, November 15). UK threw away 600,000 vaccine doses after they passed expiry date. The Independent. https://www.independent.co.uk/news/health/covid-vaccine-doses-astrazeneca-donations-uk-b1958000.html

Chise 🧬🧫🦠💉🔜 MFF. (2021, November 21). If you’re wondering what difference a booster makes. Https://t.co/858ZpST7Kh [Tweet]. @sailorrooscout. https://twitter.com/sailorrooscout/status/1462441020948459525

Breen, Liz, and Sarah Schiffling. ‘The UK’s Speedy COVID-19 Vaccine Rollout: Surprise Success or Planned Perfection?’ The Conversation. Accessed 15 November 2021. http://theconversation.com/the-uks-speedy-covid-19-vaccine-rollout-surprise-success-or-planned-perfection-155922.

What do we know about the AstraZeneca vaccine in pregnancy? (15:49:53+00:00). Full Fact. https://fullfact.org/pregnant-then-screwed/AZ-vaccine-pregnancy/

Pozzetto, B., Legros, V., Djebali, S., Barateau, V., Guibert, N., Villard, M., Peyrot, L., Allatif, O., Fassier, J.-B., Massardier-Pilonchéry, A., Brengel-Pesce, K., Yaugel-Novoa, M., Denolly, S., Boson, B., Bourlet, T., Bal, A., Valette, M., Andrieu, T., Lina, B., … Trouillet-Assant, S. (2021). Immunogenicity and efficacy of heterologous ChadOx1/BNT162b2 vaccination. Nature, 1–9. https://doi.org/10.1038/s41586-021-04120-y

Hulme, W. J., Williamson, E. J., Green, A., Bhaskaran, K., McDonald, H. I., Rentsch, C. T., Schultze, A., Tazare, J., Curtis, H. J., Walker, A. J., Tomlinson, L., Palmer, T., Horne, E., MacKenna, B., Morton, C. E., Mehrkar, A., Fisher, L., Bacon, S., Evans, D., … Goldacre, B. (2021). Comparative effectiveness of ChAdOx1 versus BNT162b2 COVID-19 vaccines in Health and Social Care workers in England: A cohort study using OpenSAFELY [Preprint]. Epidemiology. https://doi.org/10.1101/2021.10.13.21264937

Baraniuk, Chris. ‘Covid-19: How the UK Vaccine Rollout Delivered Success, so Far’. BMJ 372 (18 February 2021): n421. https://doi.org/10.1136/bmj.n421.

Study finds no increased risk of COVID-19 vaccination in pregnancy. (n.d.). Retrieved October 4, 2021, from https://www.gavi.org/vaccineswork/study-finds-no-increased-risk-covid-19-vaccination-pregnancy

Ghinwa El Hayek on Twitter. (n.d.). Twitter. Retrieved 4 October 2021, from https://twitter.com/GhinwaHayek/status/1411393046017630212

Full Fact. ‘What Do We Know about the Covid-19 Vaccines Crossing the Placenta?’, 16:58:51+00:00. https://fullfact.org/pregnant-then-screwed/vaccines-crossing-placenta/.

Kupferschmidt, K., VogelMar. 27, G., 2021, & Am, 10:20. (2021, March 27). A rare clotting disorder may cloud the world’s hopes for AstraZeneca’s COVID-19 vaccine. Science | AAAS. https://www.sciencemag.org/news/2021/03/rare-clotting-disorder-may-cloud-worlds-hopes-astrazenecas-covid-19-vaccine

Pavord, S., Scully, M., Hunt, B. J., Lester, W., Bagot, C., Craven, B., Rampotas, A., Ambler, G., & Makris, M. (2021). Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis. New England Journal of Medicine, NEJMoa2109908. https://doi.org/10.1056/NEJMoa2109908

Barros-Martins, J., Hammerschmidt, S. I., Cossmann, A., Odak, I., Stankov, M. V., Morillas Ramos, G., Dopfer-Jablonka, A., Heidemann, A., Ritter, C., Friedrichsen, M., Schultze-Florey, C., Ravens, I., Willenzon, S., Bubke, A., Ristenpart, J., Janssen, A., Ssebyatika, G., Bernhardt, G., Münch, J., … Behrens, G. M. N. (2021). Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination. Nature Medicine, 1–5. https://doi.org/10.1038/s41591-021-01449-9

Flu and Covid jabs safe to be given at same time, study finds | Vaccines and immunisation | The Guardian. (n.d.). Retrieved October 1, 2021, from https://www.theguardian.com/society/2021/sep/30/flu-covid-jabs-safe-same-time-study?CMP=Share_iOSApp_Other

Ledford, H. (2021, August 24). COVID vaccines and blood clots: What researchers know so far. Nature. https://www.nature.com/articles/d41586-021-02291-2?utm_source=twt_nat&utm_medium=social&utm_campaign=nature

Leif Erik Sander. “1/6 Our Study Comparing Reactogenicity & Immunogenicity of Homologous (2xBNT/Pfizer) vs Heterologous (AZ/ChAdOx +BNT) Vaccination Is Available Https://Medrxiv.Org/Content/10.1101/2021.05.19.21257334v2 Great Team Effort @vmcorman #FlorianKurth #DavidHillus #TatjanaSchwarz #PinkusToberLau et al. @ChariteBerlin 🧵 Https://T.Co/4zXfY4rV9c.” Tweet. @Sander_Lab (blog), June 2, 2021. https://twitter.com/Sander_Lab/status/1400178343123853321.

Kupferschmidt, K., & Vogel, G. (2021, April 11). Hard choices emerge as link between AstraZeneca vaccine and rare clotting disorder becomes clearer. Science | AAAS. https://www.sciencemag.org/news/2021/04/hard-choices-emerge-link-between-astrazeneca-vaccine-and-rare-clotting-disorder-becomes

Nasreen, Sharifa, Hannah Chung, Siyi He, Kevin A. Brown, Jonathan B. Gubbay, Sarah A. Buchan, Deshayne B. Fell, et al. “Effectiveness of COVID-19 Vaccines against Variants of Concern in Ontario, Canada,” July 16, 2021. https://doi.org/10.1101/2021.06.28.21259420.

How to trash confidence in a COVID-19 vaccine: Brexit edition—Bulletin of the Atomic Scientists. (n.d.). Retrieved August 10, 2021, from https://thebulletin.org/2021/08/how-to-trash-confidence-in-a-covid-19-vaccine-brexit-edition/#.YQwD9u6LazM.twitter

Holger Hestermeyer. (2021, March 2). As there’s a lot of ‘this is all EU politics’ out there on AZ drug admission: Some food for thought. I have deleted a lot of tweets on this. I will try to be brief, informative and neutral. (Thread) [Tweet]. @hhesterm. https://twitter.com/hhesterm/status/1366703497123672066

Reuters. (2021, July 21). Two doses of Pfizer, AstraZeneca shots effective against Delta variant: Study. Reuters. https://www.reuters.com/business/healthcare-pharmaceuticals/two-doses-pfizer-astrazeneca-shots-effective-against-delta-variant-study-finds-2021-07-21/

the Guardian. “Australian Medical Association Says NSW Covid Lockdown Failing and Urges Change to AstraZeneca Advice,” July 23, 2021. http://www.theguardian.com/australia-news/2021/jul/23/australian-medical-association-says-nsw-covid-lockdown-failing-and-urges-change-to-astrazeneca-advice.

‘Covid: UK Sends Nine Million Vaccines to Vulnerable Countries’. BBC News, 28 July 2021, sec. UK Politics. https://www.bbc.com/news/uk-politics-58004934.

McTaggart, I., & Team, G. H. S. (2021, April 9). Coronavirus latest news: France tells under-55s to abandon AstraZeneca jab for second dose. The Telegraph. https://www.telegraph.co.uk/global-health/science-and-disease/coronavirus-news-vaccine-astrazeneca-covid-blood-clots-cases/

Trust in AstraZeneca vaccine wanes across EU, survey finds. (2021, March 22). POLITICO. https://www.politico.eu/article/trust-oxford-astrazeneca-coronavirus-vaccine-wanes-europe-survey/

CitiNewsroom. (2021, July 15). The AstraZeneca Africa Director, Barbara Nel, has disclosed that a total of 1.6 billion fully funded COVID-19 vaccines would be made available for COVAX dependent countries later this year through to 2022. | Watch the full interview with @benkoku here: Https://t.co/kw3BKzMclU https://t.co/6gQ1DZMnB6 [Tweet]. @Citi973. https://twitter.com/Citi973/status/1415697599236018181

The AstraZeneca Vaccine Blood-Clot Issue Won’t Go Away—The Atlantic. (n.d.). Retrieved July 2, 2021, from https://www.theatlantic.com/health/archive/2021/03/astrazeneca-vaccine-blood-clot-issue-wont-go-away/618451/

Mahase, E. (2021). Covid-19: Third vaccine dose boosts immune response but may not be needed, say researchers. BMJ, 373, n1659. https://doi.org/10.1136/bmj.n1659

How long do COVID vaccines take to start working? (n.d.). Retrieved June 29, 2021, from https://theconversation.com/how-long-do-covid-vaccines-take-to-start-working-161876?utm_source=twitter&utm_medium=bylinetwitterbutton

‘Johnson & Johnson Vaccine Paused over Rare Blood Clots’. BBC News, 13 April 2021, sec. US & Canada. https://www.bbc.com/news/world-us-canada-56733715.

Michael Makris on Twitter: “The cumulative incidence of VITT after AZ first vaccination in the UK is continuing to increase with the latest data being 1 in 81,000. However this is rather misleading because VITT is age related with a higher incidence in the young. Https://t.co/CSjshAoRsN” / Twitter. (n.d.). Retrieved June 27, 2021, from https://twitter.com/ProfMakris/status/1395457748721184777?s=20

Staff, R. (2021, February 24). Only 15% of AstraZeneca vaccine available in Germany has been used. Reuters. https://www.reuters.com/article/us-health-coronavirus-germany-astrazenec-idUSKBN2AO1EK

Covid vaccine: US trial of AstraZeneca jab confirms safety—BBC News. (n.d.). Retrieved June 26, 2021, from https://www.bbc.co.uk/news/health-56479462

Winton Centre Cambridge. (n.d.). Retrieved June 26, 2021, from https://wintoncentre.maths.cam.ac.uk/news/communicating-potential-benefits-and-harms-astra-zeneca-covid-19-vaccine/

Association, N. S. and P. (n.d.). AstraZeneca covid-19 vaccine may hinder blood clotting in rare cases. New Scientist. Retrieved 18 June 2021, from https://www.newscientist.com/article/2280446-astrazeneca-covid-19-vaccine-may-hinder-blood-clotting-in-rare-cases/

Pishko, A. M., Bussel, J. B., & Cines, D. B. (2021). COVID-19 vaccination and immune thrombocytopenia. Nature Medicine, 1–2. https://doi.org/10.1038/s41591-021-01419-1

Pritchard, E., Matthews, P. C., Stoesser, N., Eyre, D. W., Gethings, O., Vihta, K.-D., Jones, J., House, T., VanSteenHouse, H., Bell, I., Bell, J. I., Newton, J. N., Farrar, J., Diamond, I., Rourke, E., Studley, R., Crook, D., Peto, T. E. A., Walker, A. S., & Pouwels, K. B. (2021). Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom. Nature Medicine, 1–9. https://doi.org/10.1038/s41591-021-01410-w

Page, Michael Le. “How Effective Are the Different Vaccines against Covid-19 Variants?” New Scientist. Accessed June 8, 2021. https://institutions.newscientist.com/article/mg25033363-500-how-effective-are-the-different-vaccines-against-covid-19-variants/?utm_campaign=echobox&utm_medium=social&utm_source=Twitter.

UK health minister confirms talks with AstraZeneca over new variant vaccines. (2021, June 2). Reuters. https://www.reuters.com/business/healthcare-pharmaceuticals/uk-health-minister-confirms-talks-with-astrazeneca-over-new-variant-vaccines-2021-06-02/

Iacobucci, G. (2021). Covid-19: Local councils initiate surge vaccination to tackle B.1.617.2 variant. BMJ, 373, n1361. https://doi.org/10.1136/bmj.n1361

Iacobucci, G. (2021). Covid-19: Single vaccine dose is 33% effective against variant from India, data show. BMJ, n1346. https://doi.org/10.1136/bmj.n1346

German scientists say they can help improve vaccines to prevent blood clots | Coronavirus | The Guardian. (n.d.). Retrieved May 27, 2021, from https://www.theguardian.com/world/2021/may/26/german-scientists-say-they-can-help-improve-vaccines-to-prevent-blood-clots

Vaccine confidence fears as under-30s in UK offered AstraZeneca alternative. (2021, April 7). The Guardian. http://www.theguardian.com/society/2021/apr/07/under-30s-in-uk-should-be-offered-alternative-covid-vaccine-to-astrazeneca-jab-says-regulator

Conversation, M. S., Cyra Patel and Margie Danchin for the. (2021, May 3). I’m over 50 and can now get my Covid AstraZeneca vaccine in Australia. What should I know? The Guardian. http://www.theguardian.com/society/2021/may/03/im-over-50-and-can-now-get-my-covid-astrazeneca-vaccine-in-australia-what-should-i-know

CNN Politics. (2021, May 17). President Biden announces the US will share doses of Pfizer, Moderna and Johnson & Johnson Covid-19 vaccines with other countries, in addition to 60 million doses of the AstraZeneca vaccine https://t.co/uVZo9LMH2Z https://t.co/z8YhMF3moP [Tweet]. @CNNPolitics. https://twitter.com/CNNPolitics/status/1394349919167827973

Politicians must dial down the rhetoric over COVID vaccines. (2021). Nature, 591(7851), 502–502. https://doi.org/10.1038/d41586-021-00769-7

How will covid-19 vaccine safety concerns impact vaccine confidence? (2021, April 16). The BMJ. https://blogs.bmj.com/bmj/2021/04/16/how-will-the-uks-decision-to-offer-an-alternative-to-the-oxford-astrazeneca-covid-19-vaccine-for-under-30s-following-safety-signals-impact-vaccine-confidence/

Malawi to bin 16,000 AstraZeneca doses amid fears of rise in vaccine hesitancy. (2021, April 16). The Guardian. http://www.theguardian.com/global-development/2021/apr/16/malawi-to-bin-16000-astrazeneca-doses-amid-fears-of-rise-in-vaccine-hesitancy

Winton Centre Cambridge. (n.d.). Retrieved May 12, 2021, from https://wintoncentre.maths.cam.ac.uk/news/latest-data-mhra-blood-clots-associated-astra-zeneca-covid-19-vaccine/

European Union opts not to renew AstraZeneca vaccines contract after supply row | Euronews. (n.d.). Retrieved May 12, 2021, from https://www.euronews.com/2021/05/09/european-union-opts-not-to-renew-astrazeneca-vaccines-contract-after-supply-row

Staff, R. (2021, February 6). AstraZeneca thinks shot can stop severe disease from South Africa COVID variant. Reuters. https://www.reuters.com/article/uk-health-coronavirus-astrazeneca-respon-idUKKBN2A60S2

Staff, R. (2021, February 5). AstraZeneca expects U.S. trial results in next 4-6 weeks, research chief says. Reuters. https://www.reuters.com/article/uk-health-coronavirus-astrazeneca-usa-idUSKBN2A522V

Steinhauser, G. (2021, February 7). Rollout of AstraZeneca Covid-19 Vaccine Halted in South Africa After Study. Wall Street Journal. https://www.wsj.com/articles/astrazeneca-vaccine-doesnt-protect-against-mild-and-moderate-cases-from-south-africa-strain-11612700385

the Guardian. ‘Oxford/AstraZeneca Covid Vaccine Research “Was 97% Publicly Funded”’, 15 April 2021. http://www.theguardian.com/science/2021/apr/15/oxfordastrazeneca-covid-vaccine-research-was-97-publicly-funded.

ReconfigBehSci. (2021, April 13). RT @GhinwaHayek: Are you still hesitant about AstraZeneca vaccine? Check the below video! #publichealth #vaccine #sciencework https://t.co/… [Tweet]. @SciBeh. https://twitter.com/SciBeh/status/1381980953074094089